I can't imagine anything coming out of investigation that would cause me to sell. Would not sell either way.
Sp is low, but stable for an otc biotech imo. Volume is high compared to others. I wonder if this is because of shares being issued as apart of financing?
Not saying it is a bad thing. Just can't see retail offering so many shares every day for this long without significant swings.
If sp was $5 I would be waiting. At $1.50 I am waiting & buying. Time is on our side.